SimuTech Group, founded in 2000 and based in the United States, operates within the Business Services industry, specifically focusing on custom software and IT services. The company employs between 51 and 200 individuals and has reported annual revenues of approximately $36.6 million. SimuTech Group's published content includes a research article that discusses the development of a universal advanced ventricular assist device (AVAD). This device features automatic pressure regulation and is designed to support both left and right ventricular functions. The article highlights a computational fluid dynamics (CFD) analysis aimed at assessing the device's hydraulic performance across various operating conditions. The CFD model was validated through in vitro measurements, demonstrating a high degree of accuracy in predicting hydraulic pressures and flow characteristics. The findings indicate that the AVAD can operate effectively across a wide range of flows and rotor speeds, minimizing the risk of adverse secondary flow patterns that could lead to thrombus formation. This research reflects SimuTech Group's engagement in advanced engineering and medical device innovation.